(Q39662401)

13 September 2017

title

RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain (English)

1 reference

13 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800628

3 July 2024

1

Sejin Son

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800628

3 July 2024

author name string

Do Won Hwang

2

1 reference

13 September 2017

Kaushik Singha

3

1 reference

13 September 2017

Ji Hoon Jeong

4

1 reference

13 September 2017

Tae Gwan Park

5

1 reference

13 September 2017

Dong Soo Lee

6

1 reference

13 September 2017

Won Jong Kim

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

25 August 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0168365910006668?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

https://api.elsevier.com/content/article/PII:S0168365910006668?httpAccept=text/plain

3 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Journal of Controlled Release

3 July 2024

published in

1 reference

13 September 2017

volume

155

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

18-25

1 reference

Advances in gene therapy for movement disorders.

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Gene therapy of the brain: the trans-vascular approach

3 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease

3 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Direct gene therapy for repair of the spinal cord

3 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases

3 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Use of gene therapy in central nervous system repair

3 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Gene-based treatment of motor neuron diseases

3 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Gene therapy targeting in the central nervous system

3 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Liposomal and viral vectors for gene therapy of the central nervous system.

3 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses

3 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles

3 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer

3 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Nonviral approaches for neuronal delivery of nucleic acids.

3 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Transcription start regions in the human genome are favored targets for MLV integration

3 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

AAV serotype 2 vectors preferentially integrate into active genes in mice

3 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene delivery

3 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis

3 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice

3 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes

3 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Brain-specific expression of an exogenous gene after i.v. administration

3 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

3 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer

3 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Transvascular delivery of small interfering RNA to the central nervous system.

3 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Bioreducible polymers for efficient gene and siRNA delivery

3 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier

3 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

3 July 2024

Tissue sulfhydryl groups

26

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity

3 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.

3 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Lipospermine-based gene transfer into the newborn mouse brain is optimized by a low lipospermine/DNA charge ratio

3 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells

3 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

3 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity

3 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Breaking up the correlation between efficacy and toxicity for nonviral gene delivery

3 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors

3 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Nanoprobes with near-infrared persistent luminescence for in vivo imaging.

3 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

PEGylated polyethylenimine for in vivo local gene delivery based on lipiodolized emulsion system.

3 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo

3 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.08.011

3 July 2024

Identifiers

1 reference

13 September 2017

1 reference